PT1267892E - Utilizacao de cdp-colina para o tratamento do sindrome de abstinencia de alcool - Google Patents
Utilizacao de cdp-colina para o tratamento do sindrome de abstinencia de alcoolInfo
- Publication number
- PT1267892E PT1267892E PT01936147T PT01936147T PT1267892E PT 1267892 E PT1267892 E PT 1267892E PT 01936147 T PT01936147 T PT 01936147T PT 01936147 T PT01936147 T PT 01936147T PT 1267892 E PT1267892 E PT 1267892E
- Authority
- PT
- Portugal
- Prior art keywords
- cdp
- treatment
- hill
- abstinence syndrome
- alcohol abstinence
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- RZZPDXZPRHQOCG-OJAKKHQRSA-M CDP-choline(1-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-M 0.000 abstract 2
- 206010053164 Alcohol withdrawal syndrome Diseases 0.000 abstract 1
- 208000029650 alcohol withdrawal Diseases 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200000765A ES2170649B1 (es) | 2000-03-29 | 2000-03-29 | Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1267892E true PT1267892E (pt) | 2005-03-31 |
Family
ID=8492914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01936147T PT1267892E (pt) | 2000-03-29 | 2001-03-28 | Utilizacao de cdp-colina para o tratamento do sindrome de abstinencia de alcool |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6894032B2 (https=) |
| EP (1) | EP1267892B1 (https=) |
| JP (1) | JP4724348B2 (https=) |
| KR (1) | KR100794891B1 (https=) |
| AT (1) | ATE281172T1 (https=) |
| AU (2) | AU2001262141B2 (https=) |
| BR (1) | BR0109477A (https=) |
| CA (1) | CA2402707C (https=) |
| CZ (1) | CZ298933B6 (https=) |
| DE (1) | DE60106890T2 (https=) |
| DK (1) | DK1267892T3 (https=) |
| ES (1) | ES2170649B1 (https=) |
| IL (2) | IL151163A0 (https=) |
| MX (1) | MXPA02009442A (https=) |
| NO (1) | NO329766B1 (https=) |
| NZ (1) | NZ520825A (https=) |
| PL (1) | PL199291B1 (https=) |
| PT (1) | PT1267892E (https=) |
| RU (1) | RU2251422C2 (https=) |
| WO (1) | WO2001072288A2 (https=) |
| ZA (1) | ZA200206349B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001068104A1 (en) | 2000-03-16 | 2001-09-20 | The Mclean Hospital Corporation | Compounds for the treatment of psychiatric or substance abuse disorders |
| AU2003252488A1 (en) * | 2002-07-11 | 2004-02-02 | Yamasa Corporation | Medicinal composition for drug-induced neuropathy |
| BR0316054A (pt) | 2002-11-08 | 2005-09-20 | Mclean Hospital Corp | Compostos para tratamento de dependência e privação de tabaco |
| JP4717444B2 (ja) * | 2002-12-20 | 2011-07-06 | ザ マクレーン ホスピタル コーポレーション | 睡眠／覚醒サイクルの正規化のための化合物 |
| US20050129710A1 (en) * | 2003-10-08 | 2005-06-16 | Renshaw Perry F. | Methods of treating psychiatric substance abuse, and other disorders using combinations containing omega-3 fatty acids |
| EP1765075A4 (en) | 2004-06-10 | 2010-11-10 | Mclean Hospital Corp | PYRIMIDINES, AS FORM. uridine; IN THE TREATMENT OF PATIENTS WITH MANIC-DEPRESSIVE PSYCHOSIS |
| US7947661B2 (en) | 2004-08-11 | 2011-05-24 | The Mclean Hospital Corporation | Compounds for the treatment of marihuana dependence, withdrawal, and usage |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5308627A (en) * | 1990-08-07 | 1994-05-03 | Umbdenstock Jr Anthony J | Nutritional supplement for optimizing cellular health |
| RU2072239C1 (ru) * | 1991-01-11 | 1997-01-27 | Институт биохимии СО РАМН | Способ коррекции метаболической зависимости от алкоголя и средство л.е.панина для его осуществления |
| DE4342173A1 (de) * | 1993-12-10 | 1995-06-14 | Lohmann Therapie Syst Lts | Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer |
| JP4408450B2 (ja) * | 1994-07-01 | 2010-02-03 | ウェルスタット セラピューティクス コーポレイション | 全身性炎症および炎症性肝炎の処置のためのピリミジンヌクレオチド前駆体 |
| KR100217488B1 (ko) * | 1997-06-03 | 1999-09-01 | 맹섭 | 골프채의 헤드커버 |
| RU2127589C1 (ru) * | 1997-06-03 | 1999-03-20 | Порембский Ярослав Олегович | Способ лечения стрессорных поражений нервной системы |
| US5958896A (en) | 1997-08-08 | 1999-09-28 | The Mclean Hospital | Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure |
| WO2001068104A1 (en) * | 2000-03-16 | 2001-09-20 | The Mclean Hospital Corporation | Compounds for the treatment of psychiatric or substance abuse disorders |
-
2000
- 2000-03-29 ES ES200000765A patent/ES2170649B1/es not_active Expired - Fee Related
-
2001
- 2001-03-28 AU AU2001262141A patent/AU2001262141B2/en not_active Ceased
- 2001-03-28 RU RU2002129579/15A patent/RU2251422C2/ru not_active IP Right Cessation
- 2001-03-28 MX MXPA02009442A patent/MXPA02009442A/es active IP Right Grant
- 2001-03-28 WO PCT/EP2001/003536 patent/WO2001072288A2/en not_active Ceased
- 2001-03-28 BR BR0109477-7A patent/BR0109477A/pt not_active Application Discontinuation
- 2001-03-28 KR KR1020027012966A patent/KR100794891B1/ko not_active Expired - Fee Related
- 2001-03-28 AT AT01936147T patent/ATE281172T1/de active
- 2001-03-28 EP EP01936147A patent/EP1267892B1/en not_active Expired - Lifetime
- 2001-03-28 DE DE60106890T patent/DE60106890T2/de not_active Expired - Lifetime
- 2001-03-28 CZ CZ20023245A patent/CZ298933B6/cs not_active IP Right Cessation
- 2001-03-28 IL IL15116301A patent/IL151163A0/xx active IP Right Grant
- 2001-03-28 JP JP2001570249A patent/JP4724348B2/ja not_active Expired - Fee Related
- 2001-03-28 NZ NZ520825A patent/NZ520825A/en not_active IP Right Cessation
- 2001-03-28 PL PL363177A patent/PL199291B1/pl unknown
- 2001-03-28 CA CA002402707A patent/CA2402707C/en not_active Expired - Fee Related
- 2001-03-28 US US10/240,159 patent/US6894032B2/en not_active Expired - Lifetime
- 2001-03-28 DK DK01936147T patent/DK1267892T3/da active
- 2001-03-28 PT PT01936147T patent/PT1267892E/pt unknown
- 2001-03-28 AU AU6214101A patent/AU6214101A/xx active Pending
-
2002
- 2002-08-08 ZA ZA200206349A patent/ZA200206349B/en unknown
- 2002-08-09 IL IL151163A patent/IL151163A/en not_active IP Right Cessation
- 2002-09-24 NO NO20024574A patent/NO329766B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0213358A (pt) | Uso de flibanserina | |
| AR035927A1 (es) | Compuesto de lactama (n)-((s)-2-hidroxi-3-metilbutiril)-1-(l-alaninil)-(s)-1-amino-3-metil-4,5,6,7-tetrahidro-2h-3-benzazepin-2-ona , composicion farmaceutica que lo comprende, procedimiento para la inhibicion de la liberacion de peptido b-amiloide y/o su sintesis que lo emplea y su uso para la fabr | |
| BR0015188A (pt) | Composições farmacêuticas | |
| ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
| ES2190674T3 (es) | Uso de n-alquil derivados de cadena larga de desoxinojirimicina para la fabricacion de un medicamento para el tratamiento de enfermedades de acumulacion de glucolipidos. | |
| BR0112591A (pt) | Derivados de acridina e sua aplicação como medicamento | |
| PA8529501A1 (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa -7." | |
| BR0210261A (pt) | Formulações farmacêuticas para a administração eficiente de apomorfina, 6ar-(-)-n-propil-norapomorfina e seus derivados e pró-drogas destes | |
| NO20034863L (no) | Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser | |
| BR0107899A (pt) | Processo para produzir uma preparação de ingrediente ativo compreendendo ibuprofeno, preparação de ingrediente ativo, uso da mesma, preparação farmacêutica, uso da mesma, processo para produzir formas de dosagem sólidas, e, forma de dosagem sólida | |
| BR0113590A (pt) | 7-oxo-piridopirimidinas | |
| HRP20070476T3 (en) | Treatment of dependence withdrawal | |
| SE0102440D0 (sv) | New compound | |
| PT1267892E (pt) | Utilizacao de cdp-colina para o tratamento do sindrome de abstinencia de alcool | |
| ATE360428T1 (de) | Analgetisches arzneimittel | |
| AR035006A1 (es) | Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento. | |
| AP1530A (en) | Pharmaceutical composition for intramuscular injection containing loxoprofen. | |
| BR0107160A (pt) | Uso de um éter cìclico para o preparo de medicamentos que afetam a tolerância à glicose | |
| AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante | |
| UY27372A1 (es) | Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados | |
| BR0112690A (pt) | Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos | |
| ITRM20010293A1 (it) | Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore. | |
| BR0109252A (pt) | Composto, processo para produzir um composto, composição farmacêutica, e, uso de um composto ou de uma composição | |
| BR9815993A (pt) | Comprimido de liberação cronometrada compreendendo naproxen e pseudoefedrina | |
| BR0008798A (pt) | L-arabino-dissacarìdeos de antraciclinas,processos para sua preparação e composiçõesfarmacêuticas contendo os mesmos |